Roanna Ruiz
Stock Analyst at Leerink Partners
(1.43)
# 3,670
Out of 4,690 analysts
450
Total ratings
46.5%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics | Downgraded: Hold | $7 → $1 | $0.8786 | +13.82% | 7 | Aug 7, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | $19 | $10.83 | +75.44% | 34 | Aug 6, 2026 | |
| LNTH Lantheus Holdings | Downgraded: Hold | $99 → $103 | $100.77 | +1.72% | 54 | Aug 3, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $37 | $20.02 | +84.82% | 1 | Jul 13, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | n/a | $515.46 | - | 26 | Jun 29, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $8.30 | +80.72% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Maintained: Buy | $5 → $6 | $1.36 | +341.18% | 3 | May 15, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $5.02 | +79.28% | 24 | May 15, 2026 | |
| MNKD MannKind | Maintained: Buy | n/a | $3.95 | - | 1 | Feb 25, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $72.09 | - | 30 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $16.79 | -4.71% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $13.60 | -33.82% | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $0.96 | n/a | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.48 | n/a | 35 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.89 | n/a | 27 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.29 | n/a | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $25.90 | n/a | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $3.81 | n/a | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.97 | n/a | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $153.84 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $5.36 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $6.91 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $113.88 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.0001 | n/a | 13 | Dec 20, 2022 |
Akebia Therapeutics
Aug 7, 2026
Downgraded: Hold
Price Target: $7 → $1
Current: $0.8786
Upside: +13.82%
Vir Biotechnology
Aug 6, 2026
Maintained: Buy
Price Target: $19
Current: $10.83
Upside: +75.44%
Lantheus Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: $99 → $103
Current: $100.77
Upside: +1.72%
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $20.02
Upside: +84.82%
United Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $515.46
Upside: -
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $8.30
Upside: +80.72%
iBio, Inc.
May 15, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $1.36
Upside: +341.18%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $5.02
Upside: +79.28%
MannKind
Feb 25, 2026
Maintained: Buy
Price Target: n/a
Current: $3.95
Upside: -
Cytokinetics
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $72.09
Upside: -
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $16.79
Upside: -4.71%
Oct 1, 2025
Maintained: Hold
Price Target: $7 → $9
Current: $13.60
Upside: -33.82%
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $0.96
Upside: n/a
Aug 20, 2025
Reiterated: Buy
Price Target: $9
Current: $8.48
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $28
Current: $5.89
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $2.29
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $25.90
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $3.81
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $13.97
Upside: n/a
Mar 6, 2025
Maintained: Buy
Price Target: n/a
Current: $153.84
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $5.36
Upside: n/a
May 7, 2024
Maintained: Hold
Price Target: $25
Current: $6.91
Upside: n/a
Jan 22, 2024
Maintained: Hold
Price Target: $23
Current: $113.88
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.0001
Upside: n/a